Enhancing Benefit-Risk Assessment in Regulatory Decision-Making

Enhancing Benefit-Risk Assessment in Regulator Decision-Making Enhancing Benefit-Risk Assessment in Regulatory Decision-Making | FDA An FDA guidance intended to clarify for drug sponsors and other stakeholders how considerations about a drug’s benefits, risks, and risk management options factor into certain premarket and postmarket regulatory decisions that the Agency makes about Read more…

Guidance for Patient Involvement in Regulatory Processes

Guidance for Patient Involvement in Regulatory Processes Guidance for Patient Involvement in Regulatory Processes | EUPATI “This guidance for PAGs covers patient involvement in the regulatory field and draws on the mature “Framework for interaction between the European Medicines Agency and patients and consumers and their organisations” “”Guidance for patient Read more…

How-to Guide on Patient Engagement in Clinical Trial Protocol Design

How-to Guide on Patient Engagement in Clinical Trial Protocol Design How-to Guide on Patient Engagement in Clinical Trial Protocol Design | PFMD “PFMD: The guide will give more clarity, instructions and the key terminology to Patients, Carers, Patient Organizations, Industry (Pharma, Biotech, Devices), Academia, Researchers, Contract Research Organisations (CROs) on Read more…

European Patients’ Academy on Therapeutic Innovation (EUPATI) Open Classroom

European Patients’ Academy on Therapeutic Innovation (EUPATI) Open Classroom European Patients’ Academy on Therapeutic Innovation (EUPATI) Open Classroom | EUPATI “EUPATI: Course for patient education in research and development. Free courses, personalized learning pathway, flexible e-learning, certificate course for a fee. “”EUPATI Open Classroom” by EUPATI (https://eupati.eu/) is licensed under Read more…

Select Language »